MTBVAC

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

MTBVAC is a candidate vaccine against tuberculosis in humans currently in clinical trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans. Unlike the BCG vaccine, MTBVAC contains all the antigens present in the strains that infect humans.

MTBVAC is a candidate vaccine against tuberculosis in humans currently in clinical trials. It is based on a genetically modified form of the Mycobacterium tuberculosis pathogen isolated from humans. Unlike the BCG vaccine, MTBVAC contains all the antigens present in the strains that infect humans.

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1359877130 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.